BeOne Medicines Executive and Leadership Team

John Oyler, the Co-Founder, Chairman & Chief Executive Officer at BeOne Medicines, directs the overarching strategy and vision for the global biotechnology company. Oyler guides the organization's commitment to developing innovative cancer treatments, ensuring a focus on speed, equity, and affordability in patient care. This leadership role involves setting the strategic direction for next-generation therapies and expanding their accessibility worldwide. Oyler's influence extends to fostering partnerships and driving the company's mission to improve cancer patient outcomes globally. The Chairman and Chief Executive Officer's responsibilities include overseeing all major corporate decisions and ensuring alignment with the company's core values. By championing a borderless approach to cancer treatment, John Oyler actively shapes the company's market impact and its dedication to advancing global health.

Anand Reddi, the Vice President, Chief of Staff To the Chairman and Chief Executive Officer at BeOne Medicines, provides critical strategic and operational support to the company's top leadership. Reddi assists in driving the company's mission to develop and deliver innovative cancer treatments globally, ensuring adherence to principles of speed, equity, and affordability. This role involves managing high-priority projects, facilitating executive decision-making, and enhancing the effectiveness of the Chairman and Chief Executive Officer's initiatives. The Vice President, Chief of Staff's contributions are essential for advancing BeOne Medicines' commitment to making life-saving therapies accessible to patients worldwide. By supporting executive functions, Anand Reddi directly impacts the company's ability to improve cancer patient outcomes. Reddi ensures leadership directives are executed efficiently.

Zhengqing Zhou, the Chief Financial Officer at BeOne Medicines, manages all financial operations and strategic financial planning for the global biotechnology firm. Zhou oversees budgeting, forecasting, and capital allocation, ensuring the financial health and sustainability of the company's innovative cancer treatment development. This role is critical in supporting the company's commitment to making therapies accessible worldwide, balancing affordability with the significant investment required for cutting-edge research. The Chief Financial Officer's oversight extends to financial risk management and investor relations, crucial for a company focused on global expansion and equitable healthcare delivery. By optimizing financial resources, Zhengqing Zhou directly supports BeOne Medicines' mission to improve patient outcomes through accessible, life-saving treatments. Zhou's financial acumen underpins the company's ability to execute its ambitious global strategy.

Yiwei Yu, the Chief of Staff To Global President and Chief Operating Officer at BeOne Medicines, supports the operational execution and strategic initiatives of the company's global operations. Yu plays a key part in ensuring the efficient delivery of next-generation cancer treatments, aligning with BeOne Medicines' commitment to speed, equity, and affordability. This position involves coordinating complex projects, facilitating communication across global teams, and driving operational improvements to enhance patient access to therapies. The Chief of Staff's role is crucial for translating the company's vision into tangible operational results, supporting the expansion of life-saving treatments worldwide. By optimizing operational workflows, Yiwei Yu directly contributes to BeOne Medicines' objective of improving cancer patient outcomes. Yu's support ensures the seamless functioning of global operations.

Xiaobin Wu, the Co-President & Chief Operating Officer at BeOne Medicines, directs the company's global operational strategies and execution for developing and delivering next-generation cancer treatments. Wu is instrumental in ensuring the company's commitment to speed, equity, and affordability in making these therapies accessible to patients worldwide. This leadership position involves overseeing manufacturing, supply chain, and global distribution networks to maximize patient reach and impact. The Co-President & Chief Operating Officer's responsibilities are central to translating BeOne Medicines' research innovations into tangible patient benefits across diverse global markets. By optimizing operational efficiency, Xiaobin Wu directly drives the company's mission to improve cancer patient outcomes. Wu's operational leadership ensures the effective deployment of life-saving treatments.

Danielle Abatemarco, the Chief of Staff at BeOne Medicines, provides strategic support and operational coordination across key initiatives for the biotechnology company. Abatemarco facilitates the execution of the company's mission to develop and deliver next-generation cancer treatments globally, ensuring alignment with principles of speed, equity, and affordability. This role involves managing cross-functional projects, optimizing internal processes, and enhancing communication between leadership and various departments. The Chief of Staff's responsibilities are vital for driving operational efficiency and supporting the company's commitment to making life-saving therapies accessible to patients worldwide. By streamlining operations and fostering collaboration, Danielle Abatemarco directly contributes to BeOne Medicines' goal of improving cancer patient outcomes. Abatemarco's efforts ensure the company's strategic objectives are met with precision and effectiveness.

Marcello Damiani, the Chief Technology Officer at BeOne Medicines, leads the technological infrastructure and innovation strategy for the global biotechnology company. Damiani oversees the development and implementation of cutting-edge technologies that support the research and delivery of next-generation cancer treatments. This role is fundamental to advancing the company's mission of providing accessible, affordable, and effective therapies worldwide. The Chief Technology Officer's responsibilities include managing data science initiatives, ensuring robust IT systems, and exploring novel technological solutions to accelerate drug development and patient access. By leveraging advanced technology, Marcello Damiani directly enhances BeOne Medicines' capacity to improve cancer patient outcomes globally. Damiani's technological leadership ensures the company remains at the forefront of biotech innovation.

Shiqi Chen, the Specialist, Chief Marketing Officer Site Management, Clinical Supply Chain at BeOne Medicines, focuses on optimizing the clinical supply chain to support the company's marketing and site management efforts. Chen ensures the efficient and timely delivery of critical components for next-generation cancer treatments, aligning with BeOne Medicines' commitment to accessibility and affordability. This role is vital for managing the logistics of clinical trials and product distribution, ensuring that therapies reach patients effectively worldwide. The Specialist's responsibilities include coordinating site activities and managing supply chain operations to support marketing objectives and patient access initiatives. By enhancing supply chain efficiency, Shiqi Chen directly contributes to BeOne Medicines' goal of improving cancer patient outcomes. Chen's work supports the global reach of vital treatments.

Kevin Zhou, the Chief Marketing Officer & Manager at BeOne Medicines, leads the strategic marketing initiatives and brand management for the global biotechnology company. Zhou is responsible for communicating the value and accessibility of BeOne Medicines' innovative cancer treatments to diverse patient populations and healthcare providers worldwide. This role involves developing and executing marketing strategies that emphasize speed, equity, and affordability in delivering cutting-edge therapies. The Chief Marketing Officer's oversight extends to market analysis, campaign development, and ensuring the company's message resonates globally. By driving effective marketing efforts, Kevin Zhou directly supports BeOne Medicines' mission to improve cancer patient outcomes and expand access to life-saving treatments. Zhou's marketing leadership enhances global awareness and adoption.

Chun Yi, the Global Statistics & Data Science Chief of Staff at BeOne Medicines, supports the strategic direction and operational efficiency of the company's statistics and data science functions. Yi plays a crucial role in leveraging data analytics and statistical modeling to advance the development of next-generation cancer treatments, ensuring their efficacy and accessibility. This position involves coordinating data-driven projects, facilitating collaboration between statistical teams and other departments, and ensuring that data insights support BeOne Medicines' mission of speed, equity, and affordability. The Chief of Staff's efforts are vital for translating complex data into actionable strategies that improve patient outcomes globally. By enhancing data science operations, Chun Yi directly contributes to BeOne Medicines' commitment to improving cancer patient care worldwide. Yi's support optimizes the use of data in advancing therapies.